FDA Grants Orphan Drug Status to Beam Therapeutics Inc. (BEAM)' AATD Gene Therapy
Beam Therapeutics Inc. (NASDAQ:BEAM) has secured U.S.
Beam Suntory Inc. (BEAM)
Market is closed
Sector: Beverages
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% | |
| 2. | Cheyne Capital Jonathan Lourie And Stuart Fiertz | 0 | $0 | 0% | |
| 3. | Water Island Capital John Orrico | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | LionEye Capital Management Stephen V. Raneri | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.74 | 1,500 | $89,604.00 | 1,600 | 2012-08-14 | Filing | |
| $49.80 | 20,000 | $996,054.00 | 20,000 | 2011-11-10 | Filing | |
| $52.78 | 1,245,054 | $65,713,950.12 | 20,818,545 | 2011-08-09 | Filing | |
| $52.67 | 1,543,243 | $81,282,608.81 | 19,573,491 | 2011-08-08 | Filing | |
| $54.47 | 860,215 | $46,855,911.05 | 18,030,248 | 2011-08-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $83.36 | 1,300,000 | $108,368,000.00 | 13,518,545 | 2014-01-31 | Filing | |
| $83.28 | 6,000,000 | $499,680,000.00 | 14,818,545 | 2014-01-30 | Filing | |
| $68.21 | 5,587 | $381,099.89 | 0 | 2013-11-07 | Filing | |
| $68.45 | 21,154 | $1,447,963.80 | 5,587 | 2013-11-06 | Filing | |
| $66.93 | 6,745 | $451,442.85 | 4,864 | 2013-11-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1 | $83 | 0% | |
| 2. | 1 | $54 | 0% | |
| 3. | 0 | $0 | 0% |
News See All
8 Best Gene-Editing Stocks to Buy
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
10 Best Growth Stocks to Invest in for the Next 10 Years
On March 8, Ben Snider, Goldman Sachs senior equity strategist, joined CNBC to discuss the state of the economy today.
10 Best Emerging Technology Stocks to Buy Now
The technology sector is constantly evolving, with emerging technology companies leading the charge in groundbreaking innovations.
10 Best Performing Pharma Stocks So Far in 2025
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may face under the new Trump...
Top 11 CRISPR Stocks to Invest In
The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like pharmacogenomics, digital...
10 Best Gene Therapy Stocks to Buy Right Now
Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.
10 Worst ARK Stocks To Buy According to Short Sellers
Cathie Wood of ARK Investment is one of Wall Street's most well-known hedge fund bosses.
Beam Therapeutics Inc. (NASDAQ:BEAM) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Beam Therapeutics Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end.
8 Best Small-Cap Growth Stocks to Buy According to Analysts
During the third quarter of 2024, small-cap stocks represented by the Russell 2000 Index made a strong comeback after a somewhat disappointing second quarter.
Billionaire Hedge Funds
